Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic,, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

Two infants have died and at least five have gotten sick between Sept. 17, 2021 and Jan. 4, 2022, with bacterial infections that may have been caused by contamination of baby formula made by Abbott Laboratories. The babies were infected with Cronobacter sakazakii and Salmonella Newport in Minnesota, Ohio and Texas. The illnesses and one death were first reported on Feb. 17, 2022, when Abbott issued a voluntary recall of the powdered formulas Similac, Alimentum and EleCare. After the Centers for Disease Control and Prevention (CDC) reported a second death on Feb. 28, Similac PM 60/40 was added to the…

Read More

In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the few safer options to treat pain in pregnancy, since Advil (ibuprofen) and opioids are considered riskier. They pointed out that, in some cases, a woman’s condition (fever and pain, for example) could be worse for…

Read More